Viewing Study NCT05624606


Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2025-12-30 @ 5:43 AM
Study NCT ID: NCT05624606
Status: COMPLETED
Last Update Posted: 2025-03-18
First Post: 2022-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-11-28
Start Date Type: ACTUAL
Primary Completion Date: 2024-03-28
Primary Completion Date Type: ACTUAL
Completion Date: 2024-03-28
Completion Date Type: ACTUAL
First Submit Date: 2022-11-14
First Submit QC Date: None
Study First Post Date: 2022-11-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2024-04-22
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-03-14
Last Update Post Date: 2025-03-18
Last Update Post Date Type: ACTUAL